CIK 0001101026
- Non-accelerated filer
- Smaller reporting company
Zivo Bioscience, Inc.
Sign in to watch- Ticker
- ZIVO
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870699977
- Phone
- +1 248-452-9866
- Business address
- 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
- 4 Open-market buy Director bought 668,522 shares at an average $0.12 ($82,258)
- 4 Open-market buy Director bought 14,441,202 shares at an average $0.11 ($1,523,804)
- 4 Open-market buy Director bought 340,029 shares at $0.09 ($30,603)
- 4 Open-market buy Director bought 45,000 shares at $0.08 ($3,600)
- 4 Open-market buy Director bought 70,000 shares at an average $0.07 ($4,950)
- 4 Open-market buy Director bought 15,000 shares at an average $0.08 ($1,250)
- 4 Open-market buy Director bought 82,500 shares at $0.09 ($7,425)
- 4 Open-market buy Director bought 40,000 shares at $0.09 ($3,600)
- 4 Open-market buy Director bought 30,100 shares at $0.09 ($2,709)
- 4 Open-market buy Director bought 55,000 shares at $0.09 ($4,950)
- 4 Open-market buy Director bought 45,000 shares at an average $0.11 ($5,000)
- 4 Open-market buy Director bought 95,000 shares at an average $0.12 ($11,120)
- 4 Open-market buy Director bought 496,000 shares at an average $0.11 ($54,830)
- 4 Open-market buy Director bought 90,000 shares at an average $0.10 ($9,400)
- 4 Open-market buy Director bought 85,400 shares at $0.11 ($9,394)
- 4 Open-market buy Director bought 724,500 shares at an average $0.12 ($88,985)
- 4 Open-market buy Director bought 213,000 shares at an average $0.12 ($26,170)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 61,689 shares at $0.17 ($10,487)
- 4 Open-market buy Director bought 5,017,000 shares at an average $0.10 ($502,380)
Page 6 of 12 · 239 filings